Advanced search
Publication Cover
Current Medical Research and Opinion Volume 39, 2023 - Issue 10
Submit an article Journal homepage
1,805
Views
0
CrossRef citations to date
0
Altmetric
Neurology

The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis

Helmut Butzkuevena Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia;b The Alfred Hospital, Melbourne, VIC, Australia
,
Jan Hillertc Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
,
Merja Soilu-Hänninend Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland
,
Tjalf Ziemssene Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany
,
Jens Kuhlef Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland;g Department of Neurology, University Hospital and University of Basel, Basel, Switzerland
,
Stig Wergelandh Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway;i Department of Clinical Medicine, University of Bergen, Bergen, Norway
,
Melinda Magyarij Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
,
Joseph R. Bergerk Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
,
Nicholas Moorel Bordeaux PharmacoEpi (BPE), Université de Bordeaux, Bordeaux, France
,
Aida Aydemirm EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA
,
Irene Bezemern Global Epidemiology, IQVIA, Amsterdam, The Netherlands
&
Meritxell Sabidóo Merck Healthcare KGaA, Darmstadt, GermanyCorrespondence[email protected]
 show all
Pages 1367-1374 | Received 22 May 2023, Accepted 04 Sep 2023, Published online: 19 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.